Nference (United States)

Recent papers from Nference (United States)

1. Greater lean-body-mass decline with tirzepatide than semaglutide in routine care, revealed by body-composition digital phenotypingnpj Exercise Medicine and Health · 2026
2. Somatosensory and peripheral neuropathic outcomes after semaglutide or tirzepatide initiation compared with other anti-diabetic medicationsBiology Methods and Protocols · 2026
3. Rising Documented Use of Unapproved BPC-157 and Associated Patient-Reported Outcomes Curated from Clinical NotesBiology Methods and Protocols · 2026
4. Validating ECG-Based Artificial Intelligence Models for Cardiomyopathy Detection in Obstetric PatientsJACC Advances · 2026
5. Semaglutide and Tirzepatide in Type 1 Diabetes: Real-World Insulin-Dose Reduction, Metabolic Outcomes and Safety AssessmentDiabetology · 2026
6. Higher semaglutide dose is associated with lower neuropsychiatric event incidence independent of weight lossnpj Metabolic Health and Disease · 2026
7. Comparison of Cardiometabolic Benefits and Tolerability in Patients on Sustained Low Doses of Semaglutide or TirzepatideBiology Methods and Protocols · 2026
8. Semaglutide is associated with stiffness improvement and broad liver benefits with distinct dose- and weight-linked patternsnpj gut and liver. · 2026
9. TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivoJournal of Clinical Investigation · 2026
10. Semaglutide use linked to lower COVID-19 and influenza severity with better renal outcomes after pandemic or seasonal infectionBiology Methods and Protocols · 2026
11. Semaglutide cardiovascular outcomes align more closely with attained dose than achieved weight lossnpj Cardiovascular Health · 2026
12. Auditable LLM curation of clinical notes refines GLP-1 initiation, persistence ascertainment and compounding use beyond prescription recordsBiology Methods and Protocols · 2026
13. Weight-loss dynamics with tirzepatide versus semaglutidePNAS Nexus · 2026
14. Demographics and Comorbidities of Patients With Narcolepsy: A Propensity Score–Matched Cohort Study (P6-14.010)Neurology · 2026
15. Associations between early on-treatment weight change and overall survival across targeted therapies in chronic lymphocytic leukemia.Journal of Clinical Oncology · 2026
16. Incidence, severity, and management of severe adverse events in first-line (1L) treatments for metastatic pancreatic ductal adenocarcinoma (mPDAC): A retrospective observational study.Journal of Clinical Oncology · 2026
17. Metabotyping using early body weight velocity in lung cancer patients treated with pembrolizumab.Journal of Clinical Oncology · 2026
18. A24-10 A Machine Learning Framework for Early Recognition of Pulmonary Arterial Hypertension Using Electronic Health Record DataAmerican Journal of Respiratory and Critical Care Medicine · 2026
19. A37-07 Real-world Study of Clinical Characteristics of Patients With Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine · 2026
20. 0695 Demographics and Comorbidities of Patients with Narcolepsy: A Propensity Score–Matched Cohort StudySLEEP · 2026